Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Risk of invasive pneumococcal infections among working age adults with asthma.

Klemets P, Lyytikäinen O, Ruutu P, Ollgren J, Kaijalainen T, Leinonen M, Nuorti JP.

Thorax. 2010 Aug;65(8):698-702. doi: 10.1136/thx.2009.132670.

PMID:
20685743
2.

Asthma as a risk factor for invasive pneumococcal disease.

Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA, Schaffner W, Craig AS, Griffin MR.

N Engl J Med. 2005 May 19;352(20):2082-90.

3.
4.

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.

Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF.

N Engl J Med. 2000 Mar 9;342(10):681-9.

5.

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California.

Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ.

Ann Intern Med. 2000 Feb 1;132(3):182-90.

PMID:
10651598
6.

Increased prevalence of pediatric pneumococcal serotypes in elderly adults.

Feikin DR, Klugman KP, Facklam RR, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core surveillance/Emerging Infections Program Network.

Clin Infect Dis. 2005 Aug 15;41(4):481-7. Epub 2005 Jul 11.

7.

Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country.

Levine MM, Lagos R, Levine OS, Heitmann I, Enriquez N, Pinto ME, Alvarez AM, Wu E, Mayorga C, Reyes A.

Pediatr Infect Dis J. 1998 Apr;17(4):287-93.

PMID:
9576382
8.

Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study.

Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT.

Diabetes Care. 2004 May;27(5):1143-7.

PMID:
15111535
9.

Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.

Fernández Guerrero ML, Ramos JM, Marrero J, Cuenca M, Fernández Roblas R, de Górgolas M.

Int J Infect Dis. 2003 Mar;7(1):46-52.

PMID:
12718810
10.

Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.

Arifeen SE, Saha SK, Rahman S, Rahman KM, Rahman SM, Bari S, Naheed A, Mannan I, Seraji MH, Ahmed NU, Hassan MS, Huda N, Siddik AU, Quasem I, Islam M, Fatima K, Al-Emran H, Brooks WA, Baqui AH, Breiman RF, Sack D, Luby SP.

Clin Infect Dis. 2009 Mar 1;48 Suppl 2:S103-13. doi: 10.1086/596543.

11.

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients.

Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D, Farley MM, Schuchat A, Reingold AL.

Arch Intern Med. 2000 Sep 25;160(17):2633-8.

PMID:
10999977
12.

Risk factors for invasive pneumococcal disease among Navajo adults.

Watt JP, O'Brien KL, Benin AL, McCoy SI, Donaldson CM, Reid R, Schuchat A, Zell ER, Hochman M, Santosham M, Whitney CG.

Am J Epidemiol. 2007 Nov 1;166(9):1080-7. Epub 2007 Aug 9.

13.

Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population.

Romney MG, Hull MW, Gustafson R, Sandhu J, Champagne S, Wong T, Nematallah A, Forsting S, Daly P.

Clin Infect Dis. 2008 Sep 15;47(6):768-74. doi: 10.1086/591128.

14.

Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

Vaccine. 2007 Jul 20;25(29):5390-8. Epub 2007 May 22.

PMID:
17583392
15.

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.

Foster D, Knox K, Walker AS, Griffiths DT, Moore H, Haworth E, Peto T, Brueggemann AB, Crook DW; Oxford Invasive Pneumococcal Surveillance Group.

J Med Microbiol. 2008 Apr;57(Pt 4):480-7. doi: 10.1099/jmm.0.47690-0.

PMID:
18349369
16.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

17.

Clinical characteristics and outcome of patients with invasive pneumococcal disease, Puy-de-Dôme, France, 1994-1998.

Laurichesse H, Romaszko JP, Nguyen LT, Souweine B, Poirier V, Guólon D, André M, Ruivard M, De Champs C, Caillaud D, Labbé A, Beytout J.

Eur J Clin Microbiol Infect Dis. 2001 May;20(5):299-308.

PMID:
11453589
18.

Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study.

Alanee SR, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, Ortqvist A, Rello J, Luna CM, Baddour LM, Ip M, Yu VL, Klugman KP; International Pneumococcal Study Group.

Clin Infect Dis. 2007 Jul 1;45(1):46-51. Epub 2007 May 31.

19.

Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough.

Vergison A, Tuerlinckx D, Verhaegen J, Malfroot A; Belgian Invasive Pneumococcal Disease Study Group.

Pediatrics. 2006 Sep;118(3):e801-9. Epub 2006 Aug 7.

PMID:
16894008
20.

Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.

Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.

Clin Infect Dis. 2010 May 1;50(9):1238-46. doi: 10.1086/651680.

Items per page

Supplemental Content

Write to the Help Desk